Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Post procedural haemorrhage? 930 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 930 reports of Post procedural haemorrhage have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.7% of all adverse event reports for RIVAROXABAN.

930
Reports of Post procedural haemorrhage with RIVAROXABAN
0.7%
of all RIVAROXABAN reports
135
Deaths
655
Hospitalizations

How Dangerous Is Post procedural haemorrhage From RIVAROXABAN?

Of the 930 reports, 135 (14.5%) resulted in death, 655 (70.4%) required hospitalization, and 40 (4.3%) were considered life-threatening.

Is Post procedural haemorrhage Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 930 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Post procedural haemorrhage?

LEVONORGESTREL (1,106) ASPIRIN (618) APIXABAN (539) ADALIMUMAB (476) IBRUTINIB (269) CLOPIDOGREL BISULFATE (235) HEPARIN (174) WARFARIN (170) DABIGATRAN ETEXILATE (121) COPPER (106)

Which RIVAROXABAN Alternatives Have Lower Post procedural haemorrhage Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Post procedural haemorrhage Reports All Drugs Causing Post procedural haemorrhage RIVAROXABAN Demographics